FindTrial
Sign In

Clinical study of combined with a variety of biochemical indexes to determine benign and malignant obstructive jaundice

Clinical study of combined with a variety of biochemical indexes to determine benign and malignant obstructive jaundice

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066432
Enrollment
Unknown
Registered
2022-12-05
Start date
2022-12-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive jaundice

Interventions

Benign group:N/A
Malignant group:N/A

Sponsors

Affiliated Hospital of Guilin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a. Patients with obstructive jaundice; b. Blood routine, liver function, CEA, CA199, AFP; c. Pathological examination results or follow-up confirmed diagnosis;

Exclusion criteria

Exclusion criteria: a. The patient is jaundice non-obstructive; b. The diagnosis is inconclusive;

Design outcomes

Primary

MeasureTime frame
Tumor Marker;liver function;blood routine examination;—

Countries

China

Contacts

Public ContactJiangfa Li

Affiliated Hospital of Guilin Medical University

247546160@qq.com+86 07732824373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026